David Lewandowski

David Lewandowski is an experienced professional in the fields of business development and advanced therapies, currently serving as the Director of Business Development for Advanced Therapies at AmplifyBio since January 2024. Previously, David held the position of Managing Director at Cells FX and co-chaired the ISCT Cold Chain Working Group. David's expertise is further underscored by a role as a member of the ARMI Leadership Advisory Council and a directorial position in business development for cell and gene therapy at Azenta Life Sciences. David also served as President of ISBER during 2018-2019 and held various roles in sales and business development at Cryobiosystem, Genentech, and sanofi-aventis from 1998 to 2013.